Immunovia Publishes Full Year Report for 2023 [Yahoo! Finance]
Onconetix, Inc. (ONCO)
Company Research
Source: Yahoo! Finance
Net earnings were MSEK -49 (-67) and earnings per share before and after dilution were SEK -1.08 Cash Flow from operating activities amount MSEK -28 (-51). Cash and equivalents at the end of the period amounted to MSEK 77 (106). On October 3 , the Company announced that the Nomination Committee had been appointed to consist of the following persons who together represent 7,52 percent of the total number of outstanding shares and votes in the company as of September 30, 2023 Sara Ek , Carl Borrebaeck and Mats Leifland. On October 27 , the Company gave notice that an extraordinary general meeting was to take place on November 21 On November 7 , the Company announced that the discovery phase of next generation test was successfully completed. On November 21 , the Company announced that Melissa Farina and Valerie Bogdan-Powers had been elected as new board members at the extraordinary general meeting. An adoption of an equity incentive program for the Company's management and
Show less
Read more
Impact Snapshot
Event Time:
ONCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCO alerts
High impacting Onconetix, Inc. news events
Weekly update
A roundup of the hottest topics
ONCO
News
- UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine [Yahoo! Finance]Yahoo! Finance
- Immunovia appoints Dr. Lisa Ford as Clinical Laboratory Director [Yahoo! Finance]Yahoo! Finance
- Immunovia Publishes Interim Report for January-March 2024 [Yahoo! Finance]Yahoo! Finance
- Immunovia Publishes Interim Report for January-March 2024 [Yahoo! Finance]Yahoo! Finance
- Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study [Yahoo! Finance]Yahoo! Finance
ONCO
Sec Filings
- 5/13/24 - Form 8-K
- 4/26/24 - Form S-1/A
- 4/26/24 - Form 8-K
- ONCO's page on the SEC website